Skip to the page

Data / Form D filings / Majesty Therapeutics, Inc.

Majesty Therapeutics, Inc.: Form D filing

Majesty Therapeutics, Inc., a biotechnology company in Sea Ranch Lakes, FL, filed a Form D with the SEC in 2026. The latest, on May 15, 2026, reports $100,000 sold of a $5 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
41 SENECA ROAD, Sea Ranch Lakes, FL, 33308
Phone
(561) 706-3250
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2135155

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 15, 2026New notice$5,000,000$100,000$4,900,0003May 1, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Shawn TitcombExecutive Officer, DirectorChief Executive Officer
Adrian HepnerExecutive OfficerActing Chief Medical Officer
Ankit BhargavaExecutive OfficerActing Chief Scientific Officer

Other biotechnology companies in Florida that filed recently

Every Form D from the week of May 11, 2026 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Majesty Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.